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a  b  s  t  r  a  c  t
The  mechanism  of  the  Golgi-to-ER  transport  of  Golgi  glycosyltransferases  is  not clear.  We  utilize  a cell  line
expressing  the  core  2 N-acetylglucosaminyltransferase-M  (C2GnT-M)  tagged  with  c-Myc  to  explore  this
mechanism.  By immunoprecipitation  using  anti-c-Myc  antibodies  coupled  with  proteomics  analysis,  we
have  identified  several  proteins  including  non-muscle  myosin  IIA (NMIIA),  heat  shock  protein  (HSP)-70
and ubiquitin  activating  enzyme  E1 in the  immunoprecipitate.  Employing  yeast-two-hybrid  analysis  and
pulldown  experiments,  we show  that  the  C-terminal  region  of  the  NMIIA  heavy  chain  binds  to the  1–6
amino  acids  in the  cytoplasmic  tail  of C2GnT-M.  We  have  found  that  NMIIA  co-localizes  with  C2GnT-M  at
the periphery  of the  Golgi.  In addition,  inhibition  or  knockdown  of  NMIIA  prevents  the brefeldin  A-induced
collapse  of  the  Golgi  as  shown  by the  inhibition  of  the  migration  of  both  Giantin,  a Golgi matrix  protein,
and  C2GnT-M,  a Golgi  non-matrix  protein,  to  the ER.  In contrast,  knockdown  of  HSP70  retains  Giantin  in
the Golgi  but  moves  C2GnT-M  to the ER,  a process  also  blocked  by inhibition  or knockdown  of NMIIA.
Also,  the  intracellular  distribution  of  C2GnT-M  is  not  affected  by knockdown  of -coatomer  protein  with
or without  inhibition  of  HSPs,  suggesting  that the  Golgi-to-ER  trafficking  of  C2GnT-M  does  not  depend
on  coat  protein  complex-I.  Further,  inhibition  of  proteasome  results  in accumulation  of  ubiquitinated
C2GnT-M,  suggesting  its degradation  by proteasome.  Therefore,  NMIIA  and  not  coat  protein  complex-I
is responsible  for  transporting  the  Golgi  glycosyltransferase  to  the  ER  for proteasomal  degradation.  The
data  suggest  that  NMIIA  is  involved  in the  Golgi  remodeling.
© 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Golgi structure–function relationships have been debated
among cell biologists since the discovery of the Golgi in 1898
(Marsh and Howell, 2002; Nakamura, 2010), indicating that there
is still a lot we do not know about this organelle. Golgi appara-
tus is a posttranslational modification and sorting station of the
cargos in mammalian secretory pathway. It is a dynamic organelle
constantly undergoing remodeling, and made of two groups of res-
ident proteins, matrix and non-matrix (Munro, 2011; Puri et al.,
2004). The Golgi matrix proteins, which include proteins such as
GM130, Giantin, etc., form the Golgi scaffold and can serve as the
Abbreviations: C2GnT-M/2, Core 2 1,6 N-acetylglucosaminyltransferase
mucus-type or isozyme 2; NMIIA, non-muscle myosin IIA; HSP, heat shock protein;
COP, coat protein complex.
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docking sites for transport vesicles (Appenzeller-Herzog and Hauri,
2006). The Golgi non-matrix proteins, which include enzymes such
as glycosyltransferases, carry out posttranslational modification of
the cargos as they pass through the Golgi. The Golgi glycosyltrans-
ferases are type II membrane proteins synthesized in the ER where
they acquire proper conformation with the help of chaperones such
as heat shock proteins (Walter and Buchner, 2002). Then, they are
transported to various compartments of the Golgi largely according
to the steps they participate in the assembly of conjugated glycans.
The Golgi localization signals of glycosyltransferases reside in the
N-terminal region, which includes a cytoplasmic tail, a transmem-
brane domain, and a stem (Aoki et al., 1992; Burke et al., 1994;
Colley, 1997; El-Battari, 2006; Nilsson et al., 1996). The cytoplas-
mic  tail contributes to the retention of a glycosyltransferase to
the Golgi by binding to a protein in a glycosyltransferase-specific
manner (Osman et al., 1996; Quintero et al., 2008; Wassler et al.,
2001; Schmitz et al., 2008). To date, only four mammalian gly-
cosyltransferases of which binding proteins have been identified
(Grabenhorst and Conradt, 1999; Schaub et al., 2006; Tu et al., 2008;
Tu and Banfield, 2010; Uliana et al., 2006). The ER-to-Golgi trans-
port of the Golgi proteins is also determined by the cytoplasmic tail
1357-2725/$ – see front matter ©  2012 Elsevier Ltd. All rights reserved.
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(Giraudo and Maccioni, 2003; Guo and Linstedt, 2006; Watanabe
and Riezman, 2004). Coat protein complex (COP) II is known to
be involved in the ER-to-Golgi anterograde transport of Golgi pro-
teins (King, 2000; Palmer et al., 2009; Presley et al., 1997; Storrie
et al., 1998). But, whether this applies to Golgi glycosyltransferases
is not known. Although the cytoplasmic tails of the Golgi enzymes
have been shown to be essential for their Golgi-to-ER transport
(Okamoto et al., 2008; Uemura et al., 2009), the exact role played
by the cytoplasmic tails remains to be established.
Non-muscle myosin IIA (NMIIA) is a member of the actin-based
molecular motors (Bray, 2001; Fath, 2005; Ludowyke et al., 2006;
Richards and Cavalier-Smith, 2005), which is composed of two
heavy chains and two pairs of light chains. The C-terminal region
of NMIIA heavy chains contains the cargo-binding site while the
N-terminal region contains ATPase and actin-binding sites, which
enable NMIIA to walk on actin filaments to transport the cargos
(Conti and Adelstein, 2008; Sellers, 2000). NMIIA is known to be
involved in the Golgi-to-ER transport of Golgi proteins (Duran et al.,
2003; Vazhappilly et al., 2010). However, its role in the Golgi-to-ER
transport of glycosyltransferases is not known.
In this communication, we show that core 2 N-
acetylglucosaminyltransferase-M/2 (C2GnT-M), the enzyme
that synthesizes all three 6GlcNAc branch structures found in
secreted mucins (Cheng and Radhakrishnan, 2011; Ropp et al.,
1991; Schwientek et al., 1999; Yeh et al., 1999), utilizes a COPI-
independent mechanism for its Golgi-to-ER transport. We  show
that NMIIA is responsible for transporting C2GnT-M to the ER by
binding to the cytoplasmic tail of this enzyme. After transported to
the ER, the enzyme is degraded by proteasome. We  conclude that
NMIIA is involved in transporting this Golgi enzyme to the ER for
recycling.
2. Methods
2.1. Materials
The reagents were obtained from the following suppliers: C-Myc
(mouse monoclonal and rabbit polyclonal) and -tubulin (mouse
monoclonal) Abs, Santa Cruz Biotechnology (Santa Cruz, CA); rab-
bit polyclonal Abs against the peptide GKADGAEAKPAE located
at the C-terminus of the NMIIA heavy chain, mouse monoclonal
anti--actin Ab, trypsin (Type IX), and NMIIA inhibitor Blebbis-
tatin, Sigma (St. Louis, MO); anti-human C2GnT-M goat polyclonal
Abs, Everest Biotech (Oxfordshire, UK); rabbit polyclonal Abs (anti-
Giantin, anti-protein disulfide isomerase (PDI), and anti-ubiquitin),
and mouse anti--COP and anti-HSP70 Abs, Abcam (Cambridge,
MA); horseradish peroxidase-conjugated secondary Abs (donkey
anti-rabbit, donkey anti-mouse, and donkey anti-goat), Jackson
ImmunoResearch (West Grove, PA); BFA, KNK437, and proteasome
inhibitor, MG-132, EMD  Chemicals (Brookfield, WI).
2.2. Cell culture and siRNA treatment
Panc1-bC2GnT-M (c-Myc) cells were prepared and cultured
as previously described (Choi et al., 2005). Blebbistatin, BFA,
KNK437, and MG-132 were dissolved in DMSO, and diluted in
medium immediately before use. Cells treated with a correspond-
ing amount of DMSO were used as the control. MYH9 (myosin,
heavy polypeptide 9, non-muscle), HSPA8 (heat shock 70 kDa
protein 8) and scrambled on-targetplus smartpool siRNA were pur-
chased from Dharmacon (Chicago, IL). Pool of 3 siRNAs targeting
COPB was obtained from Santa Cruz Biotechnology. Panc1-bC2GnT-
M (c-Myc) cells were transfected with 150–300 nM siRNAs using
Liofectamine RNAi MAX  reagent (Invitrogen, Carlsbad, CA). After
cultured for 72 h, cells were analyzed by Western blotting.
2.3. Co-immunoprecipitation (Co-IP) and transfection
For identification of proteins in the complexes pulled down by
Co-IP, confluent Panc1-bC2GnT-M (c-Myc) cells cultured on a T-75
flask were harvested by trypsinization, neutralized with soybean
trypsin inhibitor, and then lysed with 1.5 ml  of a non-denaturing
lysis buffer, which contained 50 mM Tris (pH 7.4), 150 mM  NaCl,
5 mM EDTA, 0.5% NP-40 (w/w), and 1% (v/v) of mammalian pro-
tease inhibitor cocktail (Sigma). One milliliter of cell lysate was
pre-cleared with 50 l of irrelevant antibody (1 mg/ml) of same
species and isotype as that to be employed for IP for 1 h at 4 ◦C.
It was followed by incubation with 100 l of a 50% slurry of
protein G plus agarose (EMD) at 4 ◦C for 1 h with gentle rock-
ing. An aliquot of the supernatant was incubated with anti-c-Myc
C2GnT-M or NMIIA Abs (1.5 g Abs to 400 g protein in 1 ml cell
lysate) overnight at 4 ◦C with gentle rocking. Then, 50 l of pro-
tein G agarose slurry was added and incubated for 1 h at 4 ◦C to
capture the immunocomplexes, which were then analyzed by SDS-
PAGE.
2.4. Gel electrophoresis and immunoblotting
Proteins were separated on SDS-PAGE on mini-gels and electro-
transferred to PVDF membranes. After blocking in PBS solution
containing 5% nonfat dried milk and 0.1% Tween-20 (PBST) at
RT for 1 h, the membranes were incubated at 4 ◦C overnight
in same blocking solution containing primary Abs. Following
washing with PBS (pH 7.4) containing 0.1% Tween-20, the mem-
branes were incubated with HRP-conjugated secondary Abs for
1 h. Immunoreactive bands were detected by Thermo Scientific
SuperSignal West Pico Chemiluminescent Substrate reagents and
exposed to BioExpress Blue Basic Autorad chemiluminescence film
(Kaysville, UT). The bands on the autoradiography films were
scanned with ScanJet 6200C (Hewlett Packard) driven by Adobe
Photoshop.
2.5. Immunofluorescence staining and confocal fluorescence
microscopy
Panc1-bC2GnT-M (c-Myc) cells grown overnight on cover
slips were fixed in 4% paraformaldehyde/PBS at RT for 30 min.
After treated with mouse anti-c-Myc and rabbit anti-NMIIA Abs
(1:100) at 37 ◦C for 1 h, the cells were stained with fluorochrome-
conjugated DyLight 488 donkey anti-mouse Ab (green), and
DyLight 594 donkey anti-rabbit Ab (red) (1:200) and mounted
in ProLong Gold antifade reagent with and without DAPI (Invit-
rogen). After deparaffinization, human bronchial epithelial tissue
sections were rinsed with water and then treated with Tris/EDTA
(pH 9) buffer in a microwave for 20 min to retrieve the antigen.
Following blocking with 1% donkey serum for 1 h at RT, the sec-
tions were incubated with anti-C2GnT-M goat polyclonal (1:50)
and rabbit polyclonal anti-Giantin Abs (1:150) for 1 h at RT, fol-
lowed by treatment for 1 h at RT with fluorochrome-conjugated
DyLight 488 donkey anti-goat Ab (green), and DyLight 594 don-
key anti-rabbit secondary Ab (red) (1:200). The treated tissue
sections were mounted in ProLong Gold antifade reagent contain-
ing DAPI. Stained cells and tissue sections were viewed under
a Zeiss 510 meta confocal laser scanning microscope. Images
were analyzed using Zeiss 510 software. For some figures, image
analysis was  performed using the Adobe Photoshop and the
ImageJ.
2.6. Proteomics analysis of electrophoretically separated proteins
The SDS-PAGE separated and Coomassie blue-stained bands
were excised, trypsinized, and treated with 60% acetonitrile
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containing 0.1% trifluoroacetic acid to extract the peptides. The pep-
tides were analyzed by the Thermo Fisher LCQ Deca Plus system
liquid chromatograph ion trap mass spectrometry with peaks sub-
jected to MS/MS  fragmentation by collision-induced dissociation.
Full mass spectra of parent ions and MS/MS  fragmentation data
were processed using BioWorks 3.2 software based on SEAQUEST
algorithm. Proteomics analysis of these protein bands was  car-
ried out by the mass spectrometry and proteomics core facility at
UNMC.
2.7. Cloning, expression and purification of the C-terminal region
of human non-muscle myosin heavy chain 9 (MYH9) in E. coli
The RNA of A549 cells was used for PCR cloning of the
cDNA of the C-terminal 1682–1960 aa of NMIIA heavy chain
9 (MYH9, accession no. NM 002473.3). The forward primer
“MYH9-For” 5′-TAGGATCCATGATCCAGTTGCAGGAGGAACTG-3′
and the reverse primer “MYH9-Rev” 5′-
ATGAATTCATTTTCGGCAGGTTTGGCCTCAGC-3′ were used. The
restriction sites BamHI and EcoRI are underlined. The purified
PCR product (840 bp) was cloned into the 3′end of the GST
fusion protein flanked by a Precision protease cleavage site (−)
located in LeuGlcValLeuPheGlnGly-Pro sequence in the pGEX-
6P-2 vector (GE health care, Piscataway, NJ). This plasmid DNA
was amplified in high efficiency competent DH5 Escherichia coli
(New England Biolab, Ipswich, MA)  and then used to transform
the BL21 (DE3) E. coli. A single clone was cultured in 100 ml  LB
medium containing ampicillin (100 g/ml). The E. coli culture at
the logarithmic phase (OD600 ∼0.6) was induced with 0.5 mM
isopropylthiogalactoside (IPTG) at 37 ◦C for 3 h. The cell pellet
was dissolved in 10 ml  lysis buffer (10 ml  PBS; 80 l 100 mM
PMSF; 10 l 1 M DTT; 80 l NP-40 and a tablet of Roche protease
inhibitor cocktail mini (Indianapolis, IN) and lysed 3 times with
French press (Thermo Scientific). The supernatant (13,000 × g,
40 min  at 4 ◦C) was mixed with 1 ml  of glutathione resin (Gen-
script, Piscataway, NJ) to immobilize the recombinant protein.
The beads were suspended in 1.5 ml  of PBS containing 40 g
of GST-tagged Precision protease (GE health care) to cleave the
recombinant protein from the resin. After rocked at 4 ◦C for 16 h,
the supernatant was mixed with 500 l of fresh glutathione resin
to remove the Precision GST-protease. The purity of the 32 kDa
recombinant MYH9 protein in the supernatant was  assessed with
10% SDS-PAGE.
2.8. Isolation of NMIIA in Panc1-bC2GnT-M (c-Myc) cell lysates
or recombinant MYH9 with biotinylated N-terminal 21 and 7
amino acid (aa) peptides of hC2GnT-M
A 21 aa peptide, which includes the cytoplasmic tail
(MVQWKRLCQLHYL) and a portion of the transmembrane domain
(WALGCYM) located at the N-terminus of hC2GnT-M, was tagged
with a biotin at the C-terminus (LifeTein LLC, South Plainfield,
NJ). A 15 aa peptide (LCQLHYLWALGCYMK) tagged with biotin at
the C-terminus served as the control. An N-terminal 7 aa peptide
(MVQWKRL) was tagged with biotin at the Met  (AAPPTec LLC,
Louisville, KY). To isolate NMIIA, 20 l of hC2GnT-M peptide in
25% acetic acid (0.1 mg/ml) was mixed with 20–40 l of cell lysate
(1.5–3.5 mg/ml  of protein) containing 5% -mercaptoethanol or
100 l of purified C-terminal part of NMIIA heavy chain 9 (MYH9)
(0.5 mg/ml). After incubation at 37 ◦C for 1 h, 100 l of Dynabeads
M-280 streptavidin (Dynal, Norway) was added. Following gentle
rotation for additional 30 min, the beads with immobilized com-
plexes were trapped with a magnet. The captured proteins were
separated on 8% SDS-PAGE followed by Western blotting with
rabbit anti-NMIIA Abs.
2.9. Trypsin digestion of the biotinylated peptide to remove the
N-terminal 6 aa’s
To identify the region of the biotinylated hC2GnT-M 21 aa pep-
tide, which binds to NMIIA, this peptide was  digested with trypsin
at RT in a 5 mM potassium-phosphate buffer, pH 7.0 for 30 min  with
an enzyme-to-substrate ratio of 1:500 by weight. After addition of
soybean trypsin inhibitor, the biotinylated peptide was isolated by
Dynabeads and then exposed to the cell lysate or MYH9 solution to
assess the ability of the biotinylated peptide to pull down NMIIA in
the cell lysate or purified MYH9 peptide.
2.10. Yeast-two-hybrid analysis of the interactions between the
1507–1960 aa peptide of the NMIIA heavy chain and the
cytoplasmic peptide of hC2GnT-M
The plasmids encoding GAL4(DBD)-C2GnT-M (1–10 aa) or
GAL4(DBD)-C2GnT-M (1–10 aa, AAA6) were co-transformed
with GAL4(AD)-NMIIA (444 aa peptide, 1507–1960, of NMIIA
heavy chain) into yeast Y2HGold (Clontech). In the other series
of experiments the plasmids encoding GAL4(DBD)-C2GnT-
M(1–14) (M1VQWKRLCQLHYLW14), GAL4(DBD)-C2GnT-M(2,3),
GAL4(DBD)-C2GnT-M(4–6), GAL4(DBD)-C2GnT-M(7–9),
GAL4(DBD)-C2GnT-M(10–12) or GAL4(DBD)-C2GnT-M(13,14)
were co-transformed with GAL4(AD)-NMIIA into yeast Y2HGold.
Interaction of GAL4(DBD) and GAL4(AD) fusion proteins enables
the cells to grow in the absence of His and in the presence
of Aureobasidin A antibiotic. Cotransformants which survive
Leu(−) and Try(−) conditions were spotted at 1.5 × 107 cells/10 l
concentration onto plates lacking His and containing 100 ng/ml
Aureobasidin A. The plates were incubated at 30 ◦C for 5–7 d before
being photographed. The Gal4(DBD)-p53 and Gal4(AD)-SV40 large
T antigen (Ali and DeCaprio, 2001) pair was used as a positive
control while Gal4(DBD)-Lamin and Gal4(AD)-SV40 large T antigen
pair was  used as a negative control.
2.11. Miscellaneous
Protein concentrations were determined with the Coomassie
Plus Protein Assay (Pierce Chemical Co., Rockford, IL) using BSA
as the standard. Data are expressed as mean ± SEM. Analysis was
performed using 2-sided t-test. A value of P < 0.05 was considered
statistically significant.
3. Results
3.1. bC2GnT-M forms complexes with NMIIA in Panc1-bC2GnT-M
(c-Myc) cells
Current study was  initiated based on a preliminary observation
that multiple c-Myc-carrying protein bands with sizes greater than
that (55 kDa) of bC2GnT-M were detected in the Panc1-bC2GnT-
M (c-Myc) cell lysates (data not shown). The results suggested that
bC2GnT-M formed complexes with other cellular proteins. To iden-
tify these proteins, the complexes were isolated from the cell lysate
using anti-c-Myc Abs plus protein G Agarose. The proteins in the
complexes were separated on SDS-PAGE under non-reducing con-
ditions and then stained with Coomassie blue (Fig. 1A). Proteomic
analysis of the 4 high molecular weight bands showed: band 1 con-
tained the heavy chains of NMIIA and NMIIB, band 2 contained
cytoskeletal keratin, type II and also heavy chains of NMIIA and IIB,
band 3 contained cytoskeletal keratin, type II, and band 4 contained
gelsolin isoform. Subsequent proteomics analysis of same samples
run under reducing conditions identified additional proteins on
Coomassie blue-stained bands. They include ubiquitin activating
enzyme E1, HSP90 1, and five different HSP70s (Fig. S1). Because
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Fig. 1. The proteins pulled down from the lysates of Panc1-bC2GnT-M (c-Myc) cells with anti-c-Myc Abs. (A) Coomassie blue stained SDS-PAGE gel analyzed on the proteins
in  the complexes pulled down from the lysate of Panc1-bC2GnT-M (c-Myc) cells with mouse anti-c-Myc Abs. (B) Tryptic peptides derived from the 250 kDa protein band in
(A)  matched to the amino acid sequence of NMIIA heavy chain. SDS-PAGE was performed on 10% gel under non-reducing condition. Proteomics analysis of these four bands
identified: non-muscle myosin IIA and IIB in 1st and 2nd bands, cytoskeletal keratin, type II in 2nd and 3rd band, and gelsolin in 4th band. The tryptic peptides are underlined.
(C)  Western blots of the cell lysates, the supernatants, and the complexes pulled down from the lysates of Panc1-bC2GnT-M (c-Myc) cells with control IgG, anti-c-Myc, or
anti-NMIIA Abs. Top panel: NMIIA heavy chain Western blot. Bottom panel: C-Myc Western blot. The signal intensities of the bands were quantitated by Image J software.
The  efficiency of the pulldown was assessed by the ratio: amount of protein detected in each IP condition/input (in %). For this calculation, we considered the input (40 g of
protein) and the amount of protein employed for the immunoprecipitation for each cell line (0.8 mg). About 90% of NMIIA and 57% of c-Myc were pulled down by anti-NMIIA
Abs,  76% of NMIIA and 97% of c-Myc were pulled down by anti-c-Myc Abs. The results shown are representative of three independent experiments.
21 tryptic peptides derived from band 1 matched the amino acid
sequence of the heavy chain of NMIIA (Fig. 1B), we chose to char-
acterize NMIIA as a possible bC2GnT-M binding partner further.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.biocel.2012.04.004.
We found that NMIIA was pulled down by anti-c-Myc Abs, and
bC2GnT-M by anti-NMIIA Abs (Fig. 1C). The results confirmed that
bC2GnT-M formed complexes with NMIIA. It was noted that about
57% of C2GnT-M was pulled down by anti-NMIIA Abs while about
76% of NMIIA was pulled down with anti-c-Myc Abs.
3.2. C2GnT-M interacts with the C-terminal region of NMIIA
heavy chain via the cytoplasmic tail
Because the cytoplasmic tails of several Golgi glycosyltrans-
ferases were shown to form complexes with cytoplasmic proteins
(Giraudo and Maccioni, 2003; Guo and Linstedt, 2006; Tu et al.,
2008), we proceeded to determine if the cytoplasmic tail of C2GnT-
M could pull down NMIIA. As shown in Fig. 2A, a C-terminally
biotinylated 1–21 aa peptide of hC2GnT-M, which contained the
cytoplasmic tail (1–7 aa, MVQWKRL), pulled down NMIIA (lane 1).
Following removal of the 6 amino acids (1–6 aa) with trypsin, the
7–21 aa peptide no longer could pull down NMIIA (lane 3). The
results were confirmed by the pulldown of NMIIA using a biotiny-
lated 1–7 aa peptide that contains the 6 aa’s removed by trypsin
(lane 2).
To identify the region of NMIIA heavy chain involved in its
interaction with C2GnT-M, we performed a pull-down of the
recombinant C-terminal region (1682–1960 aa) of the NMIIA heavy
chain with the biotinylated 1–21 aa peptide of hC2GnT-M. As
shown in Fig. 2B, the recombinant protein was  pulled down by the
1–21 aa peptide of hC2GnT-M (lane 2) but not the 7–21 aa peptide
(lane 1). These data indicate that the C-terminal portion of NMIIA
heavy chain contains the sequence responsible for NMIIA binding
to the C2GnT-M cytoplasmic tail.
The interaction of the cytoplasmic tail of hC2GnT-M with NMIIA
was confirmed by yeast-two-hybrid analysis using a 454 aa pep-
tide at the C-terminal region (1507–1960 aa) of the NMIIA heavy
chain as the prey and 1–10 aa peptide of hC2GnT-M as the bait.
The wild-type 1–10 aa peptide of hC2GnT-M showed a moderate
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Fig. 2. Interactions of NMIIA heavy chain with hC2GnT-M cytoplasmic tail. (A) Western blot of NMIIA pulled down from Panc1-bC2GnT-M (c-Myc) cell lysates with biotinylated
hC2GnT-M N-terminal peptide: 1–21 aa (lane 1), 1–7 aa (lane 2), and 7–21 aa (lane 3). The complexes pulled down with these peptides were run on 8% SDS-PAGE gel and blotted
with  rabbit anti-NMIIA Abs. Lane 4: Panc1-bC2GnT-M (c-Myc) cell lysate treated only with streptavidin dynabeads. (B) NMIIA western blot of the recombinant C-terminal
region  (1682–1960 aa) of NMIIA heavy chain pulled down with biotinylated hC2GnT-M (1–21 aa) peptide (lane 2) and control peptide (7–21 aa) (lane 1). (C) Yeast two-
hybrid  analysis of the interaction of hC2GnT-M peptide (1–10 aa) and the C-terminal 454 aa peptide (1507–1960 aa) of NMIIA heavy chain. Yeast cells at 1.5 × 107cells/10 l
suspension were plated on growth medium lacking leucine, tryptophan and histidine in the presence of 100 ng/ml Aureobasidin A. Compared with the negative control
(SV40-T antigen + Lamin), the 454 aa peptide (1507–1960 aa of the NMIIA heavy chain) showed a moderate interaction with hC2GnT-M (1–10 aa) peptide, which was reduced
after  WKR6 was  replaced with AAA6. SV40-T + p53 is a positive control. (D) hC2GnT-M peptide (1–14 aa) deletion mutants – 2,3; 4–6; 7–9; 10–12; 13,14. (E)
Yeast  two-hybrid analysis of the interaction of the C-terminal 454 aa peptide (1507–1960 aa) of NMIIA heavy chain and hC2GnT-M peptides (C2GnT-M(1–14), C2GnT-M(2,3),
C2GnT-M(4–6), C2GnT-M(7–9), C2GnT-M(10–12) and C2GnT-M(13,14). All mutants except C2GnT-M(4–6) show the growth intensity comparable to that of the wild-type
peptide in the absence of histidine and presence of Aureobasidin A.
interaction with the 454 aa peptide of the NMIIA heavy chain. The
interaction was substantially reduced when WKR6 was  replaced
with AAA6, suggesting that these three amino acids play a criti-
cal role in the binding of C2GnT-M with NMIIA (Fig. 2C). Further
experiment employing a series of deletion mutants has confirmed
the importance of WKR  for the binding of C2GnT-M with NMIIA.
As shown in Fig. 2D and E, interaction of C2GnT-M cytoplasmic tail
with NMIIA was substantially reduced after WKR6 deletion (C2GnT-
M(4–6)). However, other mutants, C2GnT-M(2,3), C2GnT-M(7–9),
C2GnT-M(10–12) or C2GnT-M(13,14), did not show an apparent
reduction in their interaction with NMIIA heavy chain when com-
pared with wild-type peptide.
3.3. Intracellular distribution of bC2GnT-M and NMIIA in
Panc1-bC2GnT-M cells
To confirm that NMIIA formed complexes with bC2GnT-
M in the cells, confocal immunofluorescence microscopy was
employed. C2GnT-M was found to co-localize with Giantin, a
Golgi matrix protein (Fig. 3A–C). Also, C2GnT-M co-localized with
NMIIA at the cytoplasmic boundary of the Golgi stacks (Fig. 3D–G,
arrows indicate peri-Golgi staining of NMIIA). Treatment with
a NMIIA inhibitor Blebbistatin (100 M,  1 h) (Chan et al., 2005;
De Pina et al., 2007; Kovács et al., 2004; Straight et al., 2003)
abolished co-localization of NMIIA with bC2GnT-M in the Golgi;
bC2GnT-M was retained in the Golgi while NMIIA was localized to
the cytoplasm (Fig. 3H–K). The results indicate that bC2GnT-M and
NMIIA no longer formed complexes in the Blebbistatin-treated
cells, and another protein was  predicted to be responsible for the
Golgi retention of C2GnT-M. That result was  confirmed by the
failure of anti-c-Myc Abs to pull down NMIIA from the lysates of
Panc1-bC2GnT-M cells treated with Blebbistatin (Fig. 3L).
We found that the Golgi localization of the recombinant C2GnT-
M produced in Panc1-bC2GnT-M (c-Myc) cells was the same as that
found in the goblet cells of human bronchial epithelium, which pro-
duces endogenous C2GnT-M (Fig. S2). The result indicates that the
Panc1-bC2GnT-M (c-Myc) cell is a suitable model for studying the
Golgi-ER trafficking of C2GnT-M.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.biocel.2012.04.004.
3.4. Inhibition or knockdown of NMIIA prevents BFA-induced
collapse of the Golgi
The biological significance of the Golgi co-localization of NMIIA
with C2GnT-M was  examined by confocal immunofluorescence
microscopy following inhibition or knockdown of NMIIA coupled
with BFA treatment. We  found that NMIIA siRNA or Blebbistatin
treatment retained bC2GnT-M in the Golgi (Fig. 4B vs. A and F
vs. G). As predicted, BFA treatment (36 M for 30 min) resulted in
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Fig. 3. Confocal immunofluorescence microscopic images of C2GnT-M, Giantin, and
NMIIA in Panc1-bC2GnT-M (c-Myc) cells. (A–C) bC2GnT-M (green) co-localizes with
Giantin (red), a Golgi matrix protein; (D–G) bC2GnT-M co-localizes with NMIIA at
the Golgi periphery (arrows indicate peri-Golgi staining of NMIIA). (H–K) Treat-
ment with a NMIIA inhibitor Blebbistatin abolishes co-localization of NMIIA with
bC2GnT-M in the Golgi; bC2GnT-M is retained in the Golgi while NMIIA is localized
in  the cytoplasm. Bars, 10 m.  G and K are enlarged images of F and J, respectively
(arrows indicate peri-Golgi co-staining of NMIIA and C2GnT-M). (L) NMIIA Western
blot of the complexes pulled down with anti-c-Myc Abs from lysates of Panc1-
bC2GnTMc(c-Myc) cells treated with DMSO (–) or Blebbistatin (+). The amount of
protein employed for the immunoprecipitation for both lane is 0.7 mg.  (For inter-
pretation of the references to color in this figure legend, the reader is referred to the
web  version of the article.)
the migration of C2GnT-M and Giantin from the Golgi to the ER
(Fig. 4C, G, J and L vs. A, E, I and K, respectively). However, treat-
ment with Blebbistatin or NMIIA siRNA followed by BFA resulted
in the retention of C2GnT-M and Giantin in the Golgi (Fig. 4D and
H). Quantitative measurement of the distribution of C2GnT-M in
the cytoplasm relative to that in the Golgi for Fig. 4A–D and E–H is
shown in Fig. 4M and N, respectively. The data indicate that NMIIA
is involved in the Golgi-to-ER retrograde transport of Golgi proteins
because inhibition or knockdown of NMIIA prevents bC2GnT-M as
well as Giantin from moving out of the Golgi even in the presence
of BFA.
3.5. Inhibition or knockdown of NMIIA inhibits the exit of
C2GnT-M from the Golgi induced by inhibition of HSPs or
knockdown of HSP70
BFA is thought to cause the collapse of the Golgi by sup-
pressing the ER-to-Golgi anterograde transport and accelerating
the Golgi-to-ER transport of Golgi proteins (Burgess et al., 1991;
Donaldson et al., 1990; Helms and Rothman, 1992; Ivessa et al.,
1995; Lippincott-Schwartz, 1993; Puri and Linstedt, 2003). The
multiple effects of BFA make this agent an undesirable Golgi disrup-
tive compound for studying Golgi remodeling. Therefore, another
agent with a simpler effect on Golgi structure is sought for studying
this phenomenon.
Because several members of HSP70 were pulled down from the
lysates of Panc1-bC2GnT-M cells with anti-c-Myc Abs (Fig. S1) and
HSPs are chaperones known to facilitate folding of proteins in the ER
and their Golgi targeting (Velez-Granell et al., 1994), we proceeded
to examine the possible involvement of HSPs in the Golgi targeting
of C2GnT-M. We  found that HSP70 co-localized with C2GnT-M in
the ER (Fig. S3) and inhibition of HSPs with KNK437 (50 M, 1 h)
(Leu et al., 2009) resulted in the retention of C2GnT-M in the ER
and Giantin in the Golgi (Fig. 5B and E vs. A and D, respectively;
Fig. 5O vs. N). However, C2GnT-M was  retained in the Golgi after
the cells were treated with Blebbistatin before KNK437 (Fig. 5C, F
and G). Similarly, cells treated with 150 nM HSP70 siRNAs showed
the retention of C2GnT-M in the ER (Fig. 5J vs. H; and L). However,
NMIIA knockdown followed by KNK437 treatment retained C2GnT-
M in the Golgi (Fig. 5K vs. I; and L). The data are consistent with the
involvement of NMIIA in the Golgi-to-ER retrograde transport of
C2GnT-M. Interestingly, KNK437 treatment or HSP70 knockdown
did not affect the Golgi architecture as shown by Giantin staining
(Fig. 5E, I and J). This observation was  different from the BFA-
induced collapse of the Golgi which was shown by the migration
of both C2GnT-M and Giantin from the Golgi to the ER (Fig. 4G and
J). Formation of complexes between C2GnT-M and HSP70 was con-
firmed by the pulldown of HSP70 from the cell lysate by anti-c-Myc
Abs (Fig. 5P).
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.biocel.2012.04.004.
3.6. ˇ-COP is not involved in the Golgi-to-ER transport of
C2GnT-M
A recent report claiming the involvement of COPI in the Golgi-
to-ER transport of peptidyl GalNAc transferases (Gill et al., 2010)
prompted us to examine whether similar transport mechanism was
also employed by C2GnT-M. We  found that knockdown of -COP
(Fig. 6F), a COPI component (Waters et al., 1991; Lee and Goldberg,
2010), did not affect intracellular distribution of C2GnT-M (Fig. 6C
vs. A; and E). Also, -COP knockdown did not affect the KNK437-
induced distribution of C2GnT-M to the ER (Fig. 6D vs. B; and E).
Next, we examined -COP distribution after inhibition of HSPs. In
the control, -COP evenly distributes throughout the cell, but after
KNK437 treatment it is primarily located to the immediate vicinity
of the Golgi (Fig. 6H vs. G). Under same conditions, C2GnT-M was
found outside of the Golgi (Fig. 6J vs. I). In addition, NMIIA inhibition
or knockdown did not alter -COP distribution (Fig. S4). Collec-
tively, the data suggest that COPI is not involved in the Golgi-to-ER
transport of C2GnT-M.
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.biocel.2012.04.004.
3.7. C2GnT-M degradation by proteasome
The identification of ubiquitin activating enzyme E1 in the com-
plexes pulled down from the lysates of Panc1-bC2GnT-M (c-Myc)
cells with anti-c-Myc Abs (Fig. S1) prompted us to examine if pro-
teasome was involved in the degradation of C2GnT-M. We  found
that treatment of Panc1-bC2GnT-M cells with MG-132 (5 M,  24 h)
resulted in an increase of not only total but also ubiquitinated
C2GnT-M (Fig. 7A–C). The bulk of the cytoplasm was occupied by
C2GnT-M in cells treated with MG-132 (Fig. 7E vs. D). In addition,
Blebbistatin treatment resulted in an increase of NMIIA (Fig. 7F and
G), but a decrease in ubiquitinated bC2GnT-M (Fig. 7H). The results
suggest that upon inhibition of NMIIA, the Golgi-to-ER retrograde
transport of bC2GnT-M is blocked, which leads to reduction of the
amount of bC2GnT-M delivered by NMIIA to the ER for degradation
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Fig. 4. NMIIA inhibition or knockdown followed by BFA treatment of Panc1-bC2GnT-M (c-Myc) cells retains C2GnT-M and Giantin in the Golgi. (A–D) Confocal immunoflu-
orescence images of C2GnT-M (green) and NMIIA (red) in cells treated with DMSO (A), Blebbistatin (B), BFA (C), and Blebbistatin followed by BFA (D). (E–H) Confocal images
of  C2GnT-M (green) and Giantin (red) in cells treated with scrambled siRNA (E), NMIIA siRNA (F), scrambled siRNA followed by BFA (G), and NMIIA siRNA followed by BFA
(H).  The images were overlaid with DIC. Bars, 10 m.  (I–L) Confocal images of C2GnT-M and Giantin in cells treated with DMSO (I) or BFA (J), and confocal images of C2GnT-M
and  an ER marker, protein disulfide isomerase (PDI) in cells treated with DMSO (K) or BFA (L). (M and N) Quantification of the intensity of bC2GnT-M fluorescence in the
cytoplasm vs. that in the Golgi (=100%) as shown in A–D and E–H, respectively. Data were obtained from 50 cells in three independent experiments and expressed as mean
percentage ± SEM; *, P < 0.001 for B, C, or D vs. A and F, G, or H vs. E. (O) NMIIA Western blot of the lysates of Panc1-bC2GnT-M cells (50 g) treated with scrambled or
NMIIA-specific siRNAs. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of the article.)
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Fig. 5. NMIIA inhibition or knockdown prevents HSP inhibition or HSP70 knockdown-induced shifting of C2GnT-M cellular localization from Golgi to ER. (A–F) Confocal
immunofluorescence images of bC2GnT-M (green) and Giantin (red) in Panc1-bC2GnT-M cells treated with DMSO (A and D), KNK437 (B and E), and Blebbistatin followed by
KNK437  (C and F). D–F are enlarged images of A–C, respectively. Bars, 10 m. (H–K) Confocal images of bC2GnT-M and Giantin in cells treated with scrambled siRNAs (H),
scrambled siRNAs followed by KNK437 (I), HSP70 siRNAs (J), and NMIIA siRNAs followed by KNK437 (K). Bars, 10 m.  (G and L) Fluorescence intensity of C2GnT-M in the
cytoplasm relative to that in the Golgi (=100%) in A–C and H–K was quantified and analyzed as described above. *, P < 0.001 for B or C vs. A, and I or J vs. H; and **, P < 0.01 for
K  vs. H. (M)  HSP70 Western blot of the lysates of cells (50 g) treated with scrambled or HSP70 specific siRNAs. KNK437 treatment or HSP70 knockdown retained Giantin in
the  Golgi and distributed bC2GnT-M to the ER. Golgi retention of both was  observed when NMIIA was  inhibited or knocked down coupled with inhibition of HSPs. (N and O)
Confocal images of C2GnT-M and an ER marker, protein disulfide isomerase (PDI) in cells treated with DMSO (N) or KNK437 (O). (P) HSP70 Western blot of the complexes
pulled down with non-specific IgG and anti-c-Myc Abs from cell lysates. The amount of protein employed for the immunoprecipitation was 0.8 mg.  (For interpretation of the
references to color in this figure legend, the reader is referred to the web version of the article.)
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Fig. 6. -COP knockdown does not affect intracellular distribution of C2GnT-M in Panc1-bC2GnT-M (c-Myc) cells with or without treatment with KNK437. (A–D) Confocal
images of bC2GnT-M and Giantin in cells treated with scrambled siRNAs (A), scrambled siRNAs followed by KNK437 (B), -COP siRNAs (C), and -COP siRNAs followed
by  KNK437 (D). Bars, 10 m. (E) Quantification of the C2GnT-M fluorescence signal in the cytosolic compartment relative to that of the Golgi (=100%). The analysis was
performed on the complete confocal stacks of 50 cells from three independent experiments. Data are expressed as mean percentage ± SEM *, P < 0.001 for B vs. A, and D vs.
C.  The bC2GnT-M distribution was not affected after -COP knockdown. KNK437 treatment has distributed bC2GnT-M to the ER even in the -COP deficiency. (F) -COP
Western blot of the lysates of cells (50 g) treated with scrambled or -COP-specific siRNAs. (G–J) Confocal images of -COP and Giantin or C2GnT-M and Giantin in cells
treated with DMSO or KNK437. Note that in control (G), -COP distributes throughout the cell, but locates primarily in the Golgi area after KNK treatment (H). Unlike -COP,
C2GnT-M moves away from the Golgi following KNK437 treatment (I and J).
by proteasome. Interestingly, MG-132 treatment also increased
NMIIA (Fig. 7F and G), suggesting that NMIIA was  also degraded
by proteasome.
4. Discussion
The cytoplasmic tails of Golgi glycosyltransferases have been
shown to be involved in the ER-to-Golgi transport (Giraudo and
Maccioni, 2003; Watanabe and Riezman, 2004; Guo et al., 2008)
and Golgi retention (Burke et al., 1994; Grabenhorst and Conradt,
1999; Uliana et al., 2006) of these enzymes. In this study, we
have expanded the functional role of the cytoplasmic tails of
glycosyltransferases by showing that they also are involved in the
Golgi-to-ER transport of these enzymes by binding to NMIIA. This
NMIIA-mediated process is likely involved in Golgi remodeling.
We have found that NMIIA directly binds to C2GnT-M through
the C-terminal 1682–1960 aa region of NMIIA heavy chain and the
4–6 aa of the cytoplasmic tail of C2GnT-M. The co-localization of
C2GnT-M with NMIIA at the periphery of the Golgi coupled with
the observation that a significant amount, i.e. 43%, of C2GnT-M is
not pulled down with anti-NMIIA Abs (Fig. 1C) suggests that there
is another pool of C2GnT-M that does not bind to NMIIA. The pro-
tein that binds to this pool of C2GnT-M is likely involved in the
Golgi retention of this enzyme and it remains to be identified. In
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Fig. 7. Proteasomal degradation of C2GnT-M in Panc1-bC2GnT-M (c-Myc) cells. (A) Western blot of bC2GnT-M in the lysates of cells (40 g) treated with DMSO or MG-132.
Cell  lysates were run on 8% SDS-PAGE with -mercaptoethanol and then probed with anti-c-Myc Abs. (B) Densitometric analysis of the protein bands in (A). Data represent
bC2GnT-M expressed relative to the density of -tubulin band and each bar represents mean ± SEM from three independent experiments. *, P < 0.001 for MG-132 vs. DMSO.
(C)  Ubiquitin Western blot of the complexes pulled down with anti-c-Myc Abs from the lysates of cells treated with DMSO or MG-132. Equal amounts of proteins in the
lysates  (0.8 mg)  were used for anti-c-Myc Co-IP. (D and E) Confocal images of bC2GnT-M and NMIIA in cells treated with DMSO (D) or MG-132 (E). (F) NMIIA Western blot of
the  lysates of cells (40 g) treated with DMSO, Blebbistatin or MG-132. The 250 kDa band corresponded to NMIIA and -tubulin was used as a control for equal loading. (G)
Densitometric analysis of the protein bands in (F). Data show the amounts of NMIIA relative to that of -tubulin and each bar represents mean ± SEM from three independent
experiments. *, P < 0.001 for Blebbistatin or MG-132 vs. DMSO. (H) Ubiquitin Western blot of anti-c-Myc (bC2GnT-M) immunoprecipitate from the lysates of Panc1-bC2GnT-M
(c-Myc) cells treated with DMSO or Blebbistatin. Co-IP samples were run on 12% SDS-PAGE with -mercaptoethanol and then probed with anti-ubiquitin Abs. The amount
of  protein employed for the immunoprecipitation for both lane was  0.7 mg.
addition, our data suggest that NMIIA is involved in the Golgi-to-ER
transport of not only C2GnT-M but also many other Golgi proteins
because inhibition of NMIIA prevents the BFA-induced collapse of
the Golgi, and the exit of many Golgi proteins including C2GnT-M
but not Giantin when HSPs are inhibited or HSP70 is depleted. In
addition, the NMIIA-mediated Golgi-to-ER transport of C2GnT-M is
independent of COPI because knockdown of -COP does not affect
the distribution of C2GnT-M under basal or KNK437 treatment
condition. Also, inhibition of NMIIA does not change -COP distri-
bution, and KNK437 treatment leaves -COP concentrated around
the Golgi. We  conclude that C2GnT-M is transported from the Golgi
to the ER in a COPI-independent process which is in good agreement
with several other reports showing an alternative route to COPI ret-
rograde transport of glycosyltransferases (Girod et al., 1999; Jiang
and Storrie, 2005; Lee et al., 2004; Storrie et al., 2000) but at variance
with one recent report which claims the involvement of COPI in the
Golgi-to-ER transport of peptidyl GalNAc transferases (Gill et al.,
2010). However, we still do not know if COPI vesicles are involved
in the intra-Golgi transportation of C2GnT-M (Cosson et al., 2002;
Guo et al., 2008; Love et al., 1998; Lanoix et al., 1999).
One major function of HSPs is to help protein folding in
the ER and Golgi targeting (Velez-Granell et al., 1994). The
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Fig. 8. Proposed role of NMIIA in the Golgi-to-ER transport of C2GnT-M. Treatment of Panc1-bC2GnT-M cells with BFA, which inhibits the ER-to-Golgi transport, results in
the  collapse of the Golgi. Inhibition (with KNK437) or knockdown (with siRNA) of HSP70, which is required for the ER-to-Golgi transport of C2GnT-M, retains C2GnT-M in the
ER  but Giantin in the Golgi. Inhibition (with Blebbistatin) or knockdown (with siRNA) of NMIIA retains C2GnT-M and Giantin in the Golgi. Subsequent treatment with BFA
or  KNK437 still retains both C2GnT-M and Giantin in the Golgi. Therefore, NMIIA is required for the Golgi-to-ER transport of C2GnT-M. Inhibition or knockdown of NMIIA
prevents the Golgi-to-ER movement of C2GnT-M even in the presence of reagents that are known to stimulate the exodus of this enzyme from the Golgi. Note that unlike
BFA,  KNK437 does not alter the Golgi morphology.
improperly folded proteins are degraded by the ER-assisted protein
degradation mechanism (Pfeffer and Rothman, 1987; Helenius
et al., 1992; Arias and Bendayan, 1993). We  have found that treat-
ment of the cells with KNK437 results in retention of Giantin in
the Golgi but accumulation of C2GnT-M in the ER. This outcome
is likely resulted from the inhibition of its anterograde transport
by KNK437 coupled with unimpeded trafficking of C2GnT-M from
Golgi to ER mediated by NMIIA (Fig. 8). The results support the role
of HSP70s in assisting the folding of C2GnT-M and subsequent traf-
ficking to the Golgi (Walter and Buchner, 2002; Triantafilou and
Triantafilou, 2004; Hartl and Hayer-Hartl, 2009). These data also
confirm the concept that Golgi is made of two different membrane
proteins, one is represented by Giantin of which Golgi retention is
resistant to KNK437, and the other one is represented by C2GnT-M
of which Golgi retention is sensitive to KNK437. This feature makes
KNK437 a useful inhibitor for studying the Golgi-to-ER retrograde
transport of glycosyltransferases because, unlike BFA, KNK437 does
not affect the Golgi architecture (Fig. 8).
We have found that C2GnT-M is degraded by proteasome
because MG-132 treatment results in accumulation of total as
well as ubiquitinated bC2GnT-M. NMIIA is involved in this process
because Blebbistatin treatment leads to accumulation of NMIIA but
a reduction in ubiquitinated bC2GnT-M. The results suggest that
the final destination of NMIIA-dependent Golgi-to-ER transport of
bC2GnT-M is proteasome. This conclusion is supported by the close
association of bC2GnT-M and ubiquitin activating enzyme E1 as
shown by the pulldown of ubiquitin activating enzyme E1 by anti-
c-Myc Abs. The accumulation of NMIIA in Panc1-bC2GnT-M cells
treated with MG-132 suggests that NMIIA is also degraded by pro-
teasome. This observation confirms a recent report showing NMIIA
involvement in proteasome-dependent degradation (Valiya Veettil
et al., 2010; Vazhappilly et al., 2010).
We have shown that our approach of using a biotinylated
cytoplasmic tail of a glycosyltransferase as a bait to isolate its
cytoplasmic binding partners is quite useful because it may  be
used as a high throughput approach for identifying the cytoplas-
mic  proteins that form complexes with a glycosyltransferase via
its tail. This should be quite useful for glycosyltransferases of
which immunoprecipitable antibodies are not yet available and
thus immuno-precipitation approach is not feasible.
Fig. 9 summarizes the results of this study. Following the synthe-
sis of C2GnT-M in the ER, C2GnT-M acquires a proper conformation
as assisted by HSP70s. This enzyme is then transported, presumably
on microtubules (McIlvain et al., 1993; Karecla and Kreis, 1992),
to the Golgi, where it is retained by binding to a protein yet to
be identified. The Golgi-to-ER retrograde transport of this enzyme,
presumably on actin filaments (De Pina et al., 2007), is determined
by its direct interaction with NMIIA via its cytoplasmic tail and the
C-terminal region of NMIIA. COPI is not involved in this process.
The enzyme along with NMIIA is then degraded by proteasome. Our
Fig. 9. Intracellular trafficking and distribution of C2GnT-M. C2GnT-M is synthe-
sized in the ER, where HSP70 helps fold C2GnT-M properly, and then transported to
the  Golgi, where the enzyme is retained by binding to a protein yet to be identified.
C2GnT-M returns to the ER in a NMIIA-dependent but COPI-independent process.
This  process is mediated by the interaction of the cytoplasmic tail (1–6 aa) of C2GnT-
M  with the C-terminal portion (1682–1960 aa) of NMIIA heavy chain. C2GnT-M is
degraded in the proteasome in a process mediated by ubiquitination.
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work has contributed to a better understanding of the intracellu-
lar trafficking of glycosyltransferases, specifically the involvement
of NMIIA in the Golgi-to-ER transport of C2GnT-M. The work also
suggests that NMIIA is involved in the Golgi remodeling.
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